Skip to main content
. Author manuscript; available in PMC: 2018 Jan 14.
Published in final edited form as: AIDS. 2017 Jan 14;31(2):287–293. doi: 10.1097/QAD.0000000000001308

Table 2.

Baseline Demographic, Laboratory and Risk Behavior Characteristics for AEH Index Cases with Acute or Early HIV infection and Recruited Partners.

Index
Cases
Recruited
Partners
Both Index Case
and Recruited
Partner
p-Value for
comparing
Index
Cases and
Recruited
Partners*

n = 98 n = 110 n = 9
Demographics
Age (median, IQR; n) 30 (24 – 37;
98)
32 (26 – 39;
107)
28 (23 – 39; 9) 0.17
Male sex (%, n) 95.9 (93/97) 95.2 (98/103) 100.0 (9/9) > 0.2
Race/ethnicity > 0.2
  White non-Hispanic 58.8 (57/97) 64.4 (65/101) 77.8 (7/9)
  Black non-Hispanic 5.2 (5/97) 5.9 (6/101) 0 (0/9)
  Hispanic 32.0 (31/97) 22.8 (23/101) 0 (0/9)
  Other (including multi-
  racial)
4.1 (4/97) 6.9 (7/101) 22.2 (2/9)
HIV transmission risk
MSM (%, n) 93.7 (89/95) 92.2 (94/102) 100.0 (9/9) > 0.2
IDU transmission Risk (%, n) 3.1 (3/98) 1 (1/100) 11.1 (1/9) > 0.2
Laboratory Data at first visit
CD4 (cells/μl), (median, IQR;
n)
504 (378 –
672; 98)
419(294 –
595; 23)
543 (390 – 633; 9) 0.045
VL (HIV-1 RNA log10
copies/ml), (median, IQR; n)
4.9 (4.0 –
5.6; 98)
4.7 (3.8 – 5.2;
23)
5.4 (4.7 – 6.0; 9) 0.10
Self-Reported Risk Behavior
in prior 3 months
Number of Partners (median,
IQR; n)
2 (1– 5; 85) 3 (1 – 6; 88) 5 (3 – 6; 7) > 0.2
Condom Use RAI (%, n) > 0.2
  -Always (100%) 11.7 (9/77) 17.3 (9/52) 33.3 (2/6)
  -Usually (50% - 99%) 29.9 (23/77) 25.0 (13/52) 16.7 (1/6)
  -Sometimes (1% - 49%) 20.8 (16/77) 26.9 (14/52) 16.7 (1/6)
  -Never (0%) 37.7 (29/77) 30.8 (16/52) 33.3 (2/6)
Methamphetamine use, any
route (%, n)
22.9 (8/35) 21.1 (4/19) 20 (1/5) > 0.2
Any drug use, any route (%,
n)
36.6 (15/41) 31.6 (6/19) 20 (1/5) > 0.2
*

Persons who were both Index Case and Recruited Partner excluded from comparison

Excluding alcohol and cannabis

Abbreviations: IDU, injection drug use; IQR, interquartile ratio; MSM, men who have sex with men; RAI, receptive anal intercourse; RPR, rapid plasma regain; VL, viral load